APOE and Alzheimer disease: However, if genetic modifiers or protective factors local to the ApoE region (e.g., cis-acting enhancers, eQTL, etc.)play a major role in ApoE ε4 heterogeneity, we would expect LA to interact with ε4 to influence AD risk.